Investigation summary: based on the information available, there was no device available for analysis and there was no report of a device performance allegation during treatment.
The reported patient symptoms is a known risks associated with water vapor therapy procedures and is noted as such in the device instructions for use.
Device history record (dhr): a dhr and ship history review cannot be performed as the lot number was not available.
Device technical analysis: the device is not available for analysis; therefore, no physical or visual analysis of the product could be performed.
Labeling review: the delivery device instructions for use (ifu) was reviewed.
The patient symptom of hematuria was found to be listed in the ifu.
Investigation conclusion: based on the information available, a conclusion code of known inherit risk of device was assigned to this investigation.
|
It was reported that during a water vapor therapy procedure, the physician pushed too hard past the right sulcus navigating over the median lobe tearing the mucosa.
However, false passage did not occur in the mucosa due to the reported delivery device manipulation.
After completing the water vapor therapy procedure, the physician felt it was necessary to use a bipolar transurethral resection of the prostate (turp) to cauterize the bleeding vessel.
The bleeding stopped and the patient was sent to recovery.
The patient is expected to fully recover and was not admitted beyond the standard of care.
|